Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

被引：0
|
作者：
Glauco Akelinghton Freire Vitiello
Marla Karine Amarante
Bruna Karina Banin-Hirata
Clodoaldo Zago Campos
Karen Brajão de Oliveira
Roberta Losi-Guembarovski
Maria Angelica Ehara Watanabe
机构：
[1] Biological Sciences Center,Department of Pathological Sciences
[2] Londrina State University,Department of Clinical Research
[3] Londrina Cancer Hospital,Department of General Biology
[4] Biological Sciences Center,Laboratory of DNA Polymorphisms and Immunology, Department of Pathological Sciences
[5] Londrina State University,Department of Clinical Medicine, Health Sciences Center
[6] Biological Sciences Center,undefined
[7] Londrina State University,undefined
[8] Londrina State University,undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 178卷
关键词：
Transforming growth factor beta; TGFBR2; Polymorphism; Breast neoplasm; Disease susceptibility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 219
页数：12
相关论文
共 19 条
  • [1] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes
    Freire Vitiello, Glauco Akelinghton
    Amarante, Marla Karine
    Banin-Hirata, Bruna Karina
    Campos, Clodoaldo Zago
    de Oliveira, Karen Brajao
    Losi-Guembarovski, Roberta
    Ehara Watanabe, Maria Angelica
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) : 207 - 219
  • [2] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism
    Yasri, Sora
    Wiwanitkit, Viroj
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 713 - 713
  • [3] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism
    Sora Yasri
    Viroj Wiwanitkit
    Breast Cancer Research and Treatment, 2019, 178 : 713 - 713
  • [4] Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”
    Glauco Akelinghton Freire Vitiello
    Marla Karine Amarante
    Bruna Karina Banin-Hirata
    Clodoaldo Zago Campos
    Karen Brajão de Oliveira
    Roberta Losi-Guembarovski
    Maria Angelica Ehara Watanabe
    Breast Cancer Research and Treatment, 2020, 179 : 519 - 520
  • [5] Authors' reply to the comment "Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism"
    Freire Vitiello, Glauco Akelinghton
    Amarante, Marla Karine
    Banin-Hirata, Bruna Karina
    Campos, Clodoaldo Zago
    de Oliveira, Karen Brajao
    Losi-Guembarovski, Roberta
    Ehara Watanabe, Maria Angelica
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 519 - 520
  • [6] A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis
    Grigorova, Antonia
    Trenova, Anastasiya
    Stanilova, Spaska
    FOLIA NEUROPATHOLOGICA, 2020, 58 (04) : 307 - 316
  • [7] Resequencing of genes for transforming growth factor β1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy
    McKnight, Amy Jayne
    Savage, David A.
    Patterson, Chris C.
    Sadlier, Denise
    Maxwell, A. Peter
    BMC MEDICAL GENETICS, 2007, 8
  • [8] Transforming Growth Factor Beta Receptor 2 (TGFBR2) Promoter Region Polymorphisms May Be Involved in Mandibular Retrognathism
    Kirschneck, Margarita
    Zbidat, Nermien
    Paddenberg, Eva
    Reis, Caio Luiz Bitencourt
    Madalena, Isabela Ribeiro
    de Menezes-Oliveira, Maria Angelica Hueb
    Lepri, Cesar Penazzo
    Proff, Peter
    Kirschneck, Christian
    Kuechler, Erika Calvano
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [9] Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients' characteristics and TGFB1 haplotypes
    Freire Vitiello, Glauco Akelinghton
    Amarante, Marla Karine
    Maeda Oda, Julie Massayo
    Banin Hirata, Bruna Karina
    Coral de Oliveira, Carlos Eduardo
    Campos, Clodoaldo Zago
    de Oliveira, Karen Brajao
    Guembarovski, Roberta Losi
    Ehara Watanabe, Maria Angelica
    CYTOKINE, 2020, 130
  • [10] Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population
    Yun, J. Y.
    Uhm, Y. K.
    Kim, H. J.
    Lim, S. H.
    Chung, J. -H.
    Shin, M. -k.
    Yim, S. -V.
    Lee, M. -H.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2010, 37 (04) : 289 - 291
12